Anhui Huaheng Biotechnology Co., Ltd. (688639.SS)
CNY 34.06
(-4.0%)
CNY 34.06
(-4.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 510.9 Million CNY | 49.37% |
| 2022 | 342.04 Million CNY | 83.56% |
| 2021 | 186.34 Million CNY | 40.79% |
| 2020 | 132.35 Million CNY | -9.32% |
| 2019 | 145.96 Million CNY | 72.81% |
| 2018 | 84.46 Million CNY | 15.75% |
| 2017 | 72.97 Million CNY | 4.7% |
| 2016 | 69.69 Million CNY | 51.72% |
| 2015 | 45.93 Million CNY | 107.36% |
| 2014 | 22.15 Million CNY | 82.62% |
| 2013 | 12.13 Million CNY | 303.97% |
| 2012 | -5.94 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 19.06 Million CNY | -71.62% |
| 2024 Q2 | 67.18 Million CNY | -29.27% |
| 2024 Q1 | 94.98 Million CNY | -33.19% |
| 2023 Q3 | 142.06 Million CNY | 5.5% |
| 2023 FY | 510.9 Million CNY | 49.37% |
| 2023 Q4 | 142.17 Million CNY | 0.07% |
| 2023 Q2 | 134.66 Million CNY | 46.38% |
| 2023 Q1 | 91.99 Million CNY | -4.88% |
| 2022 FY | 342.04 Million CNY | 83.56% |
| 2022 Q4 | 96.71 Million CNY | 3.17% |
| 2022 Q3 | 93.74 Million CNY | 7.83% |
| 2022 Q2 | 86.93 Million CNY | 34.48% |
| 2022 Q1 | 64.64 Million CNY | -14.1% |
| 2021 Q1 | 36 Million CNY | 3.48% |
| 2021 FY | 186.34 Million CNY | 40.79% |
| 2021 Q4 | 75.26 Million CNY | 74.37% |
| 2021 Q3 | 43.16 Million CNY | 35.23% |
| 2021 Q2 | 31.91 Million CNY | -11.35% |
| 2020 Q2 | 34.14 Million CNY | -14.78% |
| 2020 Q4 | 34.79 Million CNY | 48.98% |
| 2020 Q3 | 23.35 Million CNY | -31.6% |
| 2020 Q1 | 40.06 Million CNY | 27.3% |
| 2020 FY | 132.35 Million CNY | -9.32% |
| 2019 FY | 145.96 Million CNY | 72.81% |
| 2019 Q3 | 37.41 Million CNY | 0.0% |
| 2019 Q4 | 31.47 Million CNY | -15.87% |
| 2018 FY | 84.46 Million CNY | 15.75% |
| 2017 Q2 | 21.65 Million CNY | 0.0% |
| 2017 FY | 72.97 Million CNY | 4.7% |
| 2017 Q1 | 21.65 Million CNY | -0.25% |
| 2016 Q1 | 13.67 Million CNY | 48.89% |
| 2016 Q4 | 21.71 Million CNY | 0.0% |
| 2016 FY | 69.69 Million CNY | 51.72% |
| 2016 Q3 | 21.71 Million CNY | 58.74% |
| 2016 Q2 | 13.67 Million CNY | 0.0% |
| 2015 Q4 | 9.18 Million CNY | 0.0% |
| 2015 Q3 | 9.18 Million CNY | -36.71% |
| 2015 Q2 | 14.51 Million CNY | -0.0% |
| 2015 FY | 45.93 Million CNY | 107.36% |
| 2015 Q1 | 14.51 Million CNY | 939.2% |
| 2014 FY | 22.15 Million CNY | 82.62% |
| 2014 Q4 | -1.72 Million CNY | 0.0% |
| 2014 Q3 | -1.72 Million CNY | -113.18% |
| 2014 Q2 | 13.12 Million CNY | -0.0% |
| 2014 Q1 | 13.12 Million CNY | 139.85% |
| 2013 Q3 | 5.47 Million CNY | 54.32% |
| 2013 Q2 | 3.54 Million CNY | -0.0% |
| 2013 Q1 | 3.54 Million CNY | 0.0% |
| 2013 FY | 12.13 Million CNY | 303.97% |
| 2013 Q4 | 5.47 Million CNY | 0.0% |
| 2012 FY | -5.94 Million CNY | 0.0% |